Cargando…
Correction: Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436866/ https://www.ncbi.nlm.nih.gov/pubmed/28542604 http://dx.doi.org/10.1371/journal.pone.0178338 |
_version_ | 1783237485389676544 |
---|---|
author | Talmage, Garrick D. Coppes, Oscar J. M. Javed, Adil Bernard, Jacqueline |
author_facet | Talmage, Garrick D. Coppes, Oscar J. M. Javed, Adil Bernard, Jacqueline |
author_sort | Talmage, Garrick D. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5436866 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-54368662017-05-27 Correction: Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study Talmage, Garrick D. Coppes, Oscar J. M. Javed, Adil Bernard, Jacqueline PLoS One Correction Public Library of Science 2017-05-18 /pmc/articles/PMC5436866/ /pubmed/28542604 http://dx.doi.org/10.1371/journal.pone.0178338 Text en © 2017 Talmage et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Correction Talmage, Garrick D. Coppes, Oscar J. M. Javed, Adil Bernard, Jacqueline Correction: Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study |
title | Correction: Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study |
title_full | Correction: Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study |
title_fullStr | Correction: Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study |
title_full_unstemmed | Correction: Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study |
title_short | Correction: Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study |
title_sort | correction: natalizumab stabilizes physical, cognitive, mri, and oct markers of disease activity: a prospective, non-randomized pilot study |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436866/ https://www.ncbi.nlm.nih.gov/pubmed/28542604 http://dx.doi.org/10.1371/journal.pone.0178338 |
work_keys_str_mv | AT talmagegarrickd correctionnatalizumabstabilizesphysicalcognitivemriandoctmarkersofdiseaseactivityaprospectivenonrandomizedpilotstudy AT coppesoscarjm correctionnatalizumabstabilizesphysicalcognitivemriandoctmarkersofdiseaseactivityaprospectivenonrandomizedpilotstudy AT javedadil correctionnatalizumabstabilizesphysicalcognitivemriandoctmarkersofdiseaseactivityaprospectivenonrandomizedpilotstudy AT bernardjacqueline correctionnatalizumabstabilizesphysicalcognitivemriandoctmarkersofdiseaseactivityaprospectivenonrandomizedpilotstudy |